Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 220

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials

Open access
Howard, Virginia J, Meschia, James F, Lal, Brajesh K, Turan, Tanya N, Roubin, Gary S, Brown, Robert D, Voeks, Jenifer H, Barrett, Kevin M, Demaerschalk, Bart M, Huston, John, Lazar, Ronald M, Moore, Wesley S, Wadley, Virginia G, Chaturvedi, Seemant, Moy, Claudia S, Chimowitz, Marc, Howard, George, Brott, Thomas G · 2017 · International Journal of Stroke

Abstract

Rationale: Trials conducted decades ago demonstrated that carotid endarterectomy by skilled surgeons reduced stroke risk in asymptomatic patients. Developments in carotid stenting and improvements in medical prevention of stroke caused by atherothrombotic disease challenge understanding of the benefits of revascularization. Aim: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) will test whether carotid endarterectomy or carotid stenting plus contemporary intensive medical therapy is superior to intensive medical therapy alone in the primary prevention of stroke in patients with high-grade asymptomatic carotid stenosis. Methods and design: CREST-2 is two multicenter randomized trials of revascularization plus intensive medical therapy versus intensive medical therapy alone. One trial randomizes patients to carotid endarterectomy plus intensive medical therapy versus intensive medical therapy alone; the other, to carotid stenting plus intensive medical therapy versus intensive medical therapy alone. The risk factor targets of centrally directed intensive medical therapy are LDL cholesterol <70 mg/dl and systolic blood pressure <140 mmHg. Study outcomes: The primary outcome is the composite of stroke and death within 44 days following randomization and stroke ipsilateral to the target vessel thereafter, up to four years. Change in cognition and differences in major and minor stroke are secondary outcomes. Sample size: Enrollment of 1240 patients in each trial provides 85% power to detect a treatment difference if the event rate in the intensive medical therapy alone arm is 4.8% higher or 2.8% lower than an anticipated 3.6% rate in the revascularization arm. Discussion: Management of asymptomatic carotid stenosis requires contemporary randomized trials to address whether carotid endarterectomy or carotid stenting plus intensive medical therapy is superior in preventing stroke beyond intensive medical therapy alone. Whether carotid endarterectomy or carotid stenting has favorable effects on cognition will also be tested. Trial registration: United States National Institutes of Health Clinicaltrials.gov NCT02089217

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1747493017706238

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 220

Metadata

Authors
Howard, V. J., Meschia, J. F., Lal, B. K., Turan, T. N., Roubin, G. S., Brown, R. D., Voeks, J. H., Barrett, K. M., Demaerschalk, B. M., Huston, J., Lazar, R. M., Moore, W. S., Wadley, V. G., Chaturvedi, S., Moy, C. S., Chimowitz, M., Howard, G., & Brott, T. G.
Venue
International Journal of Stroke
Published
2017-05-02
Volume
12
Issue
7
Pages
770-778
ISSN
  • 1747-4930 (ISSN-L)
  • 1747-4949
OpenAlex
W2610523530
Cited by
220
References
1
FWCI
16.20
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials. https://app.cochat.ai/papers/10.1177/1747493017706238
The paper
Howard, V. J., Meschia, J. F., Lal, B. K., Turan, T. N., Roubin, G. S., Brown, R. D., Voeks, J. H., Barrett, K. M., Demaerschalk, B. M., Huston, J., Lazar, R. M., Moore, W. S., Wadley, V. G., Chaturvedi, S., Moy, C. S., Chimowitz, M., Howard, G., & Brott, T. G. (2017). Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials. International Journal of Stroke. https://doi.org/10.1177/1747493017706238

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.